Working… Menu

The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet (FORMULA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00138645
Recruitment Status : Completed
First Posted : August 30, 2005
Results First Posted : June 10, 2009
Last Update Posted : February 8, 2016
Sunny Health Co., Ltd.
Information provided by (Responsible Party):
Corby K. Martin, Pennington Biomedical Research Center

Brief Summary:
It is hypothesized that the use of a partial supplement diet, which includes the use of meal replacements, will result in significantly greater weight loss after three and six months compared to an isocaloric diet that does not include supplements. It is also hypothesized that the partial supplement diet will result in larger improvements in body composition, disease biomarkers, and health parameters (blood pressure, lipids) compared to the non-supplement diet. Finally, it is hypothesized that subjective ratings of satiety will be significantly higher, and ratings of hunger lower, in the group consuming a partial supplement diet.

Condition or disease Intervention/treatment Phase
Body Weight Changes Behavioral: MicroDiet Behavioral: Healthy Diet Phase 4

Detailed Description:

In recent decades, the prevalence of overweight and obesity has increased dramatically in developed countries. Obesity is associated with diseases such as diabetes, cardiovascular disease, hypertension, and certain cancers. Modest amounts of weight loss (e.g., 5% to 10% of initial body weight) significantly improve health and improve disease status. Recent evidence suggests that the use of supplements or meal replacements promotes greater weight loss than isocaloric food-based diets. In addition, diets that are high in protein are associated with greater ratings of satiety and reduced food intake, as well as greater weight loss, compared to lower protein diets.

The purpose of the proposed study is to test the effect of a partial supplement diet on body weight, body composition, and biomarkers for disease compared to an isocaloric diet that consists of a traditional food-based meal plan. Overweight and obese (BMI 25 to 35) participants will participate in this six-month study. The primary outcome variable is body weight loss and the secondary outcome variables include body composition, blood pressure, lipids, and subjective ratings of satiety.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: The Effects of Formula Diet on Body Weight, Body Composition, and Biomarkers for Disease Compared to a Standard Diet
Study Start Date : April 2005
Actual Primary Completion Date : May 2006
Actual Study Completion Date : May 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Body Weight

Arm Intervention/treatment
Experimental: MicroDiet
Participants randomized to the MicroDiet group (1200 kcal/day) will be instructed by a Registered Dietitian to consume (one shake and 3 cookies; 240 kcal) for two meals each day for Months 1 through 3. They will be provided with meal plans for the meal that they do not replace with MicroDiet. During Months 4 through 6, participants in the MicroDiet group will be instructed to replace one meal per day with MD (the energy content of the meal plan will still be 1200 kcal/day). Participants will also be encouraged to eat or drink MD for snacks. The rest of the diet will consist of healthy foods, as outlined above. To help participants adhere to the MicroDiet regimen, they will meet with a registered dietitian for one hour at Week 0 and 30 minutes at Weeks 2 and 4, and every month thereafter.
Behavioral: MicroDiet

Active Comparator: Healthy Diet
Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet. The Healthy Diet will consist of the same foods that are used in the meal plans for the MicroDiet group. The Healthy Diet group will be instructed not to use meal replacements such as shakes (e.g., Slim Fast®), nutrition bars (e.g., Balance Bar®), or portion-controlled meals (e.g., Healthy Choice entrees).
Behavioral: Healthy Diet
Participants randomized to the Healthy Diet group will be prescribed a traditional food-based diet that contains the same number of kilocalories (1200/day) as the MicroDiet but will be instructed not to use meal replacements

Primary Outcome Measures :
  1. Body Weight Loss (kg and Percent) at Months 3 and 6 [ Time Frame: April 2005 to May 2006 ]
  2. Percent Change in Body Weight (Completers). [ Time Frame: 24 weeks ]
    Percent change in body weight from baseline to week 24(completers).

Secondary Outcome Measures :
  1. Change in Body Composition at Months 3 and 6 [ Time Frame: April 2005 to May 2006 ]
  2. Disease Biomarkers (Cholesterol, Triglycerides, Etc.) at Months 3 and 6 [ Time Frame: April 2005 to May 2006 ]
  3. Subjective Ratings of Appetite at Week 2 and Months 1, 2, 3, 4, 5, and 6 [ Time Frame: April 2005 to May 2006 ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male or female gender; of all ethnic backgrounds.
  • Healthy person who has not been diagnosed with diabetes, cardiovascular illness, renal, hepatic or other chronic diseases
  • > 17 years and < 66 years of age
  • Body mass index (BMI; kg/m2) between 25 and 35
  • For females with the potential to bear children, they meet one of the following criteria:

    • They are willing to use an acceptable method of birth control (e.g., oral contraceptive tablets, implanted contraceptive hormones, Depo-Provera® contraceptive injections, intrauterine devices, prophylactic condoms with spermicide, contraceptive diaphragms with spermicide, cervical caps with spermicide), or are in a monogamous relationship with a partner who has had a vasectomy.
    • They are sexually abstinent and intend to continue this practice, at least for the duration of the study.

Exclusion Criteria:

  • > 65 years and < 18 years of age
  • Regular use of medications other than birth control, vitamins or hormone replacement therapy
  • Diabetes mellitus (fasting blood sugar [FBS] > 126); persons with impaired glucose tolerance (FBS 100-125) may be admitted to the study.
  • Use of tobacco products
  • Depression or mental illness requiring treatment or medication within the last six months
  • For women, pregnancy, breast feeding, postpartum < 6 months, planning a pregnancy during the study, or are not using an acceptable method of contraception
  • Use of medications or herbal supplements that affect appetite or body weight for the previous three months
  • Patients requiring restriction of protein intake
  • Impaired kidney function (creatinine > 1.5) or liver function (liver enzymes > 3 times the upper limits of normal)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00138645

Layout table for location information
United States, Louisiana
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808
Sponsors and Collaborators
Pennington Biomedical Research Center
Sunny Health Co., Ltd.
Layout table for investigator information
Principal Investigator: Corby K. Martin, Ph.D. Pennington Biomedical Research Center

Layout table for additonal information
Responsible Party: Corby K. Martin, Associate Professor, Pennington Biomedical Research Center Identifier: NCT00138645     History of Changes
Other Study ID Numbers: PBRC 25004
First Posted: August 30, 2005    Key Record Dates
Results First Posted: June 10, 2009
Last Update Posted: February 8, 2016
Last Verified: January 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Body Weight
Body Weight Changes
Signs and Symptoms